Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo.
Clinical Trials
Relapsed Grade 2/3 IDH-mutant glioma
Open
LUMOS2
Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided Therapies
A Randomised Phase II study of Veliparib, Radiotherapy and Temozolomide in patients with unmethylated O (6)-methylguanine-DNA methyltransferase (MGMT) Glioblastoma